Aslan Fred
SEC CIK 1909362 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | Pres, CEO, Dir | 1.60M | — | $1.45M | 16 | 2024-07-22 | 2026-09-15 |
Most active insiders at ARTV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $92.68M | — |
| 2 | GC Corp. | 10% | $16.50M | — |
| 3 | Aslan Fred | Pres, CEO, Dir | — | $1.38M |
| 4 | Banerjee Subhashis | Chief Medical Off | — | $179.5K |
| 5 | Horan Christopher | Chief Tech Ops Off | — | $178.7K |
| 6 | Bush Jennifer | COO, CLO, Secy, Compliance Off | — | $172.8K |
| 7 | Raymon Heather | SVP, Research, Development | — | $27.9K |
| 8 | Krishnamohan Neha | CFO | — | — |
| 9 | Miralles Gines Diego | Pres, Head of R, D | — | — |
| 10 | Huston Thad Allen | CFO | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 16:44 | 2026-09-15 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO, Dir | A - Grant | $0.00 | +110.0K | 1.60M | +7% | $0 |
| D | 2026-09-14 20:07 | 2026-09-10 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO, Dir | A - Grant | $0.00 | +45.0K | 1.49M | +3% | $0 |
| T | 2026-09-09 16:02 | 2026-09-08 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO, Dir | S - Sale | $10.92 | -23.4K | 1.45M | -2% | -$255.7K |
| 2026-09-04 16:02 | 2026-09-03 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO, Dir | S - Sale | $11.16 | -61.9K | 1.47M | -4% | -$690.4K | |
| 2026-05-19 21:50 | 2026-05-19 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO, Dir | S - Sale | $9.01 | -27.1K | 1.54M | -2% | -$244.3K | |
| 2026-02-18 | 2026-02-15 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | F - Tax | $4.00 | -14.6K | 1.56M | -0.9% | -$58.4K | |
| 2026-02-18 | 2026-02-15 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +366.9K | 1.58M | +30% | $0 | |
| T | 2025-12-15 | 2025-12-15 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | S - Sale | $6.00 | -3,187 | 1.21M | -0.3% | -$19.1K |
| D | 2025-12-12 | 2025-12-12 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +869.1K | 1.21M | +253% | $0 |
| T | 2025-11-17 | 2025-11-15 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | F - Tax | $3.25 | -6,347 | 350.4K | -2% | -$20.6K |
| T | 2025-11-17 | 2025-11-17 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | S - Sale | $3.38 | -6,375 | 344.0K | -2% | -$21.5K |
| 2025-10-17 | 2025-10-17 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | S - Sale | $6.00 | -25.5K | 356.7K | -7% | -$153.0K | |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | F - Tax | $2.44 | -8,944 | 382.2K | -2% | -$21.8K |
| 2025-08-18 | 2025-08-15 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | S - Sale | $2.73 | -25.5K | 386.7K | -6% | -$69.6K | |
| 2025-03-07 | 2025-03-05 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 416.7K | +92% | $0 | |
| D | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +228.9K | 228.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations